eli lilly cease and desist tirzepatide weight loss drug data released Eli Lilly's Popular Weight Loss
Description
Related products: Retatrutide, Retatrutide 10mg, Retatrutide 20mg, Retatrutide 40mg, Retatrutide 20mg Pen, Retatrutide 40mg Pen
Significance statement ![Figure][1] ### Competing Interest Statement The authors have declared no competing interest
Expert guidance for patients and clinicians.
Stuck on semaglutide or tirzepatide
Considering weight loss solutions can be overwhelming and confusing, especially with the abundance of options available today
Among the subset of patients for whom post-prescription dispensing data is available, we describe the proportion and characteristics of patients who were and were not dispensed a GLP-1 RA following their prescription
